Featured
News
UK’s First Varian Halcyon Cancer Treatment Systems Scheduled...
Cancer patients in the U.K. will gain access to the country’s first Varian Halcyon™ radiotherapy treatment devices when the first of two systems are delivered...
Research Insight
The Parker Institute and Cancer Research Institute Announce...
The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute announced the first patients have begun treatment in a new pancreatic cancer multi-center clinical trial....
News
InterVapor Bronchoscopic Thermal Vapor Ablation (BTVA) is Back...
The InterVapor® Bronchoscopic Thermal Vapor Ablation (BTVA®) is back on the market after a brief hiatus as the asset sale of Uptake Medical Corporation was...
News
Cardiac SPECT solution at the American Society of...
Royal Philips , a global leader in health technology, today announced its presence at the American Society of Nuclear Cardiology’s Annual Scientific Session in Kansas...
Industry Reports
NuVasive announces acquisition of Vertera spine medical device...
NuVasive, Inc. , a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced the acquisition of Vertera Spine, a...
News
Novartis receives first ever FDA approval for a...
Novartis announced that the US FDA has approved Kymriahâ„¢(tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for...
Press Releases
AstraZeneca highlights latest advances in lung cancer at...
At the European Society of Medical Oncology (ESMO) 2017 Congress in Madrid, Spain, 8-12 September, AstraZeneca and MedImmune, its global biologics research and development arm,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.